(Q38205664)

31 August 2017

title

Itraconazole and clarithromycin as ketoconazole alternatives for clinical CYP3A inhibition studies (English)

1 reference

31 August 2017

1 reference

A B Ke

1

1 reference

31 August 2017

M J Zamek-Gliszczynski

series ordinal

2

1 reference

31 August 2017

J W Higgins

series ordinal

3

1 reference

31 August 2017

S D Hall

series ordinal

4

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 May 2014

1 reference

Clinical Pharmacology & Therapeutics

31 August 2017

published in

1 reference

31 August 2017

volume

95

1 reference

31 August 2017

issue

5

1 reference

31 August 2017

page(s)

473-476

1 reference

Optimization of drug-drug interaction study design: comparison of minimal physiologically based pharmacokinetic models on prediction of CYP3A inhibition by ketoconazole

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.41

Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.41

Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.41

Accurate prediction of dose-dependent CYP3A4 inhibition by itraconazole and its metabolites from in vitro inhibition data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.41

Physiologically based pharmacokinetic modeling of intestinal first-pass metabolism of CYP3A substrates with high intestinal extraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2014.41

21 January 2018

Identifiers

DOI

10.1038/CLPT.2014.41

1 reference

31 August 2017

1 reference